NLRP3 and Sepsis: demonstrated that inhibition of the NLRP3 inflammasome attenuated sepsis-induced platelet activation and prevented thrombosis, suggesting a potential role for NLRP3 in the development of coagulation disorders in sepsis patients with ARDS (29).